GSK has sold a 4.2% shareholding in Haleon, the group behind the Sensodyne, Panadol and Centrum consumer health brands which spun out of GSK in November 2022.
GlaxoSmithKline offloads 4.2% stake in Haleon
Share
Join our network of executives who receive the MBS News daily, as well as the insights, analysis and our weekly column in The Weekend Edition.
You’ll be able to unsubscribe at any time.